Mackenzie Financial Corp decreased its holdings in Davita Inc (NYSE:DVA) by 0.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,557,975 shares of the company’s stock after selling 3,817 shares during the quarter. Mackenzie Financial Corp’s holdings in Davita were worth $112,564,000 at the end of the most recent reporting period.
Other institutional investors have also modified their holdings of the company. Carnegie Capital Asset Management LLC bought a new stake in Davita during the fourth quarter valued at $4,767,000. Hudson Bay Capital Management LP bought a new stake in Davita during the fourth quarter valued at $11,970,000. Tavio Capital LLC bought a new stake in Davita during the fourth quarter valued at $15,110,000. Standard Life Aberdeen plc boosted its position in Davita by 3.4% during the fourth quarter. Standard Life Aberdeen plc now owns 74,835 shares of the company’s stock valued at $5,408,000 after acquiring an additional 2,429 shares during the last quarter. Finally, OppenheimerFunds Inc. boosted its position in Davita by 5,292.6% during the fourth quarter. OppenheimerFunds Inc. now owns 1,873,918 shares of the company’s stock valued at $135,391,000 after acquiring an additional 1,839,168 shares during the last quarter. 82.88% of the stock is currently owned by institutional investors.
Davita Inc (DVA) opened at $72.02 on Thursday. The stock has a market cap of $13,407.94, a PE ratio of 20.94, a PEG ratio of 1.41 and a beta of 0.99. The company has a current ratio of 2.88, a quick ratio of 2.82 and a debt-to-equity ratio of 1.87. Davita Inc has a 1 year low of $52.51 and a 1 year high of $80.71.
In related news, insider James K. Hilger sold 3,572 shares of the company’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $78.95, for a total value of $282,009.40. Following the sale, the insider now owns 33,649 shares in the company, valued at approximately $2,656,588.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Kent J. Thiry sold 81,800 shares of the company’s stock in a transaction dated Friday, December 8th. The stock was sold at an average price of $68.04, for a total transaction of $5,565,672.00. The disclosure for this sale can be found here. Insiders sold a total of 121,509 shares of company stock worth $8,310,388 in the last 90 days. 2.10% of the stock is currently owned by company insiders.
A number of analysts have commented on DVA shares. Raymond James Financial raised shares of Davita from an “outperform” rating to a “strong-buy” rating and upped their price target for the company from $65.00 to $84.00 in a research report on Thursday, December 7th. Royal Bank of Canada cut their price objective on shares of Davita from $64.00 to $60.00 and set a “sector perform” rating on the stock in a research report on Wednesday, November 8th. Bank of America raised shares of Davita from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $75.00 to $85.00 in a research report on Thursday, January 4th. Robert W. Baird reissued a “hold” rating and set a $63.00 price objective on shares of Davita in a research report on Friday, November 10th. Finally, KeyCorp reissued a “hold” rating on shares of Davita in a research report on Monday, November 13th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, four have issued a buy rating and two have given a strong buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $79.30.
ILLEGAL ACTIVITY WARNING: This news story was first reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3230600/mackenzie-financial-corp-has-112-56-million-position-in-davita-inc-dva.html.
Davita Company Profile
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.